Short Interest in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Expands By 205.9%

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the target of a significant growth in short interest in the month of December. As of December 15th, there was short interest totaling 4,328 shares, a growth of 205.9% from the November 30th total of 1,415 shares. Based on an average daily trading volume, of 1,514 shares, the short-interest ratio is presently 2.9 days. Approximately 2.9% of the company’s stock are short sold. Approximately 2.9% of the company’s stock are short sold. Based on an average daily trading volume, of 1,514 shares, the short-interest ratio is presently 2.9 days.

iShares Neuroscience and Healthcare ETF Trading Down 0.5%

iShares Neuroscience and Healthcare ETF stock traded down $0.15 during trading hours on Friday, hitting $32.47. 496 shares of the stock traded hands, compared to its average volume of 792. iShares Neuroscience and Healthcare ETF has a one year low of $17.86 and a one year high of $33.32. The firm’s 50-day moving average price is $30.56 and its two-hundred day moving average price is $26.55. The company has a market cap of $4.87 million, a PE ratio of 15.61 and a beta of 0.93.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.